Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progress of the disease
As the volume and depth of genomic data grows, bioinformaticians are translating genomic data into interpretable patterns leading to new biological insight.
19 mammals were included in the study reconstructing chromosome rearrangements during 105 million years of mammalian evolution
The new approach finds what Wigler believes is the first rigorous statistical evidence that ancient variations in the human genome contribute to autism
This puts NewLink Genetics further back behind Incyte Corporation in the race to develop a new series of cancer-fighting drugs called IDO inhibitors
Intellia Therapeutics has been granted a broad patent covering CRISPR/Cas9 single guide gene-editing methods and compositions
A research team manages to characterise the complete epigenomes of the most frequent tumours, including those of colon, lung and breast cancer.
Guardant Health has announced that it has made an alliance with Pfizer Oncology to support several clinical trial programs
The combination of the two companies expertise and strengths will maximize the potential to make breakthroughs neither partner could alone